Search
Tuesday 15 September 2015
  • :
  • :
Latest Update

News Buzz on: Viavi Solutions Inc(NASDAQ:VIAV), Accenture Plc(NYSE:ACN), Atwood Oceanics, Inc.(NYSE:ATW), Amicus Therapeutics, Inc.(NASDAQ:FOLD)

On Tuesday, Viavi Solutions Inc(NASDAQ:VIAV)’s shares inclined 1.26% to $5.62.

Viavi Solutions Inc. (NASDAQ: VIAV) declared it is expanding its portfolio of software-defined network test and monitoring solutions with the new GigaStor Software Edition to manage performance and user experience in virtual and cloud environments. The new software configurations, which Viavi is demonstrating at VMworld, allow network and server teams to capture and save 250 GB or 1 TB of continuous traffic to disk for in-depth performance and forensic analysis.

Without GigaStor’s insight, engineers could spend hours replicating a network error before they can diagnose its cause. GigaStor Software captures packet-data from within the virtual switching infrastructure without needing to push data into the physical environment. It can be deployed in any virtual host for the long-term collection and saving of packet-level data, which it can decode, analyze, and display. Additionally, it provides IT teams with greater accuracy and speed in troubleshooting by having all packets accessible for immediate analysis.

Viavi Solutions Inc. engages in the network enablement, service enablement, and communications and commercial optical products businesses. The company’s Network Enablement segment provides an integrated portfolio of testing solutions that access the network to perform build out and maintenance tasks. This segment’s solutions comprise instruments, software, and services to design, build, turn-up, certify, troubleshoot, and optimize netoperates. Its Service Enablement segment offers embedded systems and enterprise performance administration solutions for global service providers, enterprises, and cloud operators.

Accenture Plc(NYSE:ACN)’s shares gained 2.83% to $97.12.

Accenture Plc (ACN) declared the acquisition of Brightstep — a provider of digital content and commerce solutions. The move is part of Accenture’s efforts to enhance its digital marketing capabilities. However, the company has not revealed the terms of the deal.

Based in Stockholm, Sweden, Brightstep was formed in 2001. Brightstep provides brand e-commerce and digital marketing services. Apart from this, its portfolio comprises technology development, and design and usability services. Furthermore, it provides services to improve the brand identity of its clients on the digital platform and enhance their online presence.

The acquisition will assist Accenture’s clients gain access to a greater number of professionals specializing in digital e-commerce solutions from Intershop, hybris software and Adobe.

Brightstep will join the Accenture Interactive platform, a part of the company’s digital marketing-services arm, Accenture Digital. Accenture Interactive was formed in 2009 to deliver managed consulting, technology and analytics services to chief marketing officers (CMOs).

Accenture plc provides administration consulting, technology, and business process outsourcing services worldwide. The company’s Communications, Media & Technology segment offers enterprise and industry-customized services in network engineering and integration, field force enablement, and IP network migration; provides online customer and enterprise relationship administration services; and assists customers in developing video-over-IP platforms, and transforming legacy broadcast platforms to digital.

At the end of Tuesday ‘s trade, Atwood Oceanics, Inc.(NYSE:ATW)‘s shares surged 3.10% to $17.31.

Atwood Oceanics, Inc. (ATW) declared that its board of directors has declared a quarterly cash dividend of $0.25 per share of common stock, payable on October 8, 2015 to shareholders of record as of 5:00 p.m., New York City time, on October 1, 2015.

Atwood Oceanics, Inc. is a leading offshore drilling company engaged in the drilling and completion of exploration and development wells for the global oil and gas industry. The Company presently owns 11 mobile offshore drilling units and is constructing two ultra-deepwater drillships. The Company was founded in 1968 and is headquartered in Houston, Texas. Atwood Oceanics, Inc. common stock is traded on the New York Stock Exchange under the symbol “ATW.”

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells worldwide. As of November 10, 2014, it owned a fleet of 13 mobile offshore drilling units, in addition to 3 ultra-deepwater drill ships under construction. The company was founded in 1968 and is headquartered in Houston, Texas.

Amicus Therapeutics, Inc.(NASDAQ:FOLD), ended its Tuesday ‘s trading session with 11.72% gain, and closed at $17.35.

Amicus Therapeutics (FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, recently declared financial results for the second quarter ended June 30, 2015. The Company also offered program updates and reiterated full-year 2015 net cash spend guidance of $100 million to $110 million.

Financial Highlights for Second Quarter Ended June 30, 2015

  • Cash, cash equivalents, and marketable securities totaled $361.4 million at June 30, 2015, contrast to $169.1 million at December 31, 2014.
  • Total operating expenses raised to $26.9 million contrast to $14.7 million for the second quarter 2014, primarily due to enhances in preclinical and clinical development costs on the Fabry monotherapy and Pompe ERT programs.
  • Net loss was $27.1 million, or $0.27 per share, contrast to a net loss of $14.6 million, or $0.22 per share, for the second quarter 2014.

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its product candidate is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease. The company’s development programs comprise next-generation ERTs for lysosomal storage disorders (LSDs), such as Fabry disease, Pompe disease, and Mucopolysaccharidosis Type I.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *